Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity : a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH)
Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity : a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH)
Brunning RD, Matutes E, Harris NL, Flandrin G, Vardiman J, Bennett J et al. Acute myeloid leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001 pp 75-108.
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al., On behalf of the Medical Research Council Adult-and Children's Leukemia Working Parties. The importance of diagnosis cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322-2333.
Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al., For the Southwest Oncology Group and the Eastern Cooperative Oncology Group. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukaemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000; 96: 4075-4083.
Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukaemia: Results from Cancer and Leukaemia Group B (CALGB 8461). Blood 2002; 100: 4325-4336.
Kern W, Haferlach T, Schoch C, Löffler H, Gassmann W, Heinecke A et al. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long term outcome in acute myeloid leukernia:. data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood 2003; 101: 64-70.
Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T. Acute myeloid leukemia with a complex karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 2005; 43: 227-238.
ISCN. An International System for Human Cytogenetic Nomenclature. In: Shaffer LG, Tommerup N (eds). S Karger: Basel, 2005.
Leymarie V, Flandrin G, Noguera ME, Leymarie F, Lioure B, Daliphard S, And the GOELAMS cytologists (Groupe ouest-est des leucémies aiguës et autres maladies du sang). Telehematology: A pilot experience of cytological diagnosis of acute myeloid lukemia via the internet. A GOELAMS study. Haematologica 2005; 91: 1285-1286.
Schoch C, Haferlach T, Bursch S, Gerstner D, Schnittger S, Dugas M et al. Loss of genetic material is more common-than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed anlysis of 125 cases using conventional chromosome analysis and fluorescence in situ Nybridization including, 24-color FISH. Genes Chromosomes Cancer 2002; 35: 20-29.
Schoch C, Kohlmann A, Dugas M, Kern W, Schnittger S, Haferlach T. Impact of trisomy 8 on expression of genes, located on chromosome 8 in different AML subgroups. Genes Chromosómes cancer 2006; 45 1164-1168.
Paulsson K, Heidenblad M, Strombeck B, Staaf J, Jonsson G, Borg A et al. High-resolution, genome wide-array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with-Irisomy 8 as the sole cytogenetic aberration. Leukemia 2006; 20: 840-846.
Paulsson K, Panagopoulos I, Knuutila S, Jee KJ, Garwicz S, Fioretos T et al. Formation of trisomies and their parental origin in hyperdiploid childhood acute lymphoblastic leukemia. Blood 2003; 102; 3010-3015.
Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caliguiri MA et al. Expression profiling reveals fundamental biological differences in acute myeloid leukaemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 2001; 98: 1124-1129.
Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S et al. Genomic gains and losses influence expression levels of genes located within the affected regions: A study on acute myeloid leukemias with trisomy 8, 11 or 13 and monosomy 7 or deletion 5q. Leukemia 2005; 19: 1224-1228.
Vledman T, Vignon C, Schrock E, Rowley JD, Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 1997; 15: 406-410.
Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F et al Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998; 58: 55-59.
von Bergh A, Emmanuel B, van Zelderen-Bhola S, Smetsers T, van Soest R, Stul M et al. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias. Genes Chromosomes Cancer 2000; 28: 14-22.
Mitelman F, Johansson B, Mertens F (eds). Mitelman Database of Chromosomes Aberrations in Cancer [Internet] 2007. available from http://cgap.nci.nih.gov/Chromosomes/Mitelman,accessed on January 2007.
Schoch C, Schnittger S, Klaus M, Hiddemann W, Haferlach T. AML with 11q23/MLL abnormalities is defined by the WHO classification: Incidence, partner chromosomes, FAB subtype, age distribution and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003; 102: 2395-2402.
Bloomfield CD, Archer KJ, Mrozek K, Lillington DM, Kancho Y, Head DR et al. 11q23 Balanced chromosomes aberrations in treatment related myelodysplastic syndromes and acute leukaemia: Report from an international workshop. Genes Chromosomes Cancer 2002; 33: 362-378.
Paulsson K, Heidenblad M, Mörse H; Borg A, Fioretos T, Johansson B. Identification of cryptic aberrations and characterization of translocation breakpoints using array CGH in high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia 2006; 20: 2002-2007.
